OXON WEBINAR SERIES 2019/20

Understanding Health Care for Field and Secondary Data Observational Studies
in the EU and Asian Countries

Created with Sketch.

Overview

A webinar series from leading national pharmacoepidemiologists spread over many months to provide a phased educational experience to learn about health care for conducting optimal observational studies.

European and Asian pharmaco-epidemiologists and project managers experienced in Safety and Outcomes observational studies will make presentations and provide practical guidance based on their experience with drugs and vaccines. 

Monthly from March 2019

More than 10 different countries

LEARN MORE

Leading pharmacoepidemiologist

Upcoming webinars

Dates and times: Monthly from March 2019 at 5pm CET | 4pm UK | 11am EDT | 8am PST
Language: English

SPAIN – October 2019 (date TBD)
Speaker to be confirmed
Multi-country field studies – November 2019 (date TBD)
Speaker to be confirmed
Multi-country database studies – December 2019 (date TBD)
Speaker to be confirmed
JAPAN – 2020 (date TBD)
Speaker: Prof. Masao Iwagami
TAIWAN – 2020 (date TBD)
Speaker: Prof. Yea-Huei Kao Yang
SOUTH KOREA – 2020 (date TBD)
Speaker: Prof. Ju-Young Shin
CHINA – 2020 (date TBD)
Speaker to be confirmed
Pregnancy Studies – 2020 (date TBD)
Speaker to be confirmed
Risk Minimisation Studies – June 2020 (date TBD)
Speaker: Prof. Marie Louise De Bruin

Meet the experts

Local knowledge and data access with leading native epidemiologists in key EU and Asian countries, with whom OXON can collaborate in studies.

Join us! It will only take a minute

OXON: YOUR OBSERVATIONAL STUDIES SERVICE PROVIDER

Let us help design and conduct your optimal
PASS or Outcomes observational study 

OXON epidemiologists, statisticians, clinicians and project managers (ex-big pharma, ex-EMA), supported by consultancy from Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine (´Pocock Stopping Rule´, sat on many data monitoring committees, extensive experience with EMA and FDA, classic textbook ´Clinical Trials´, 30+ NEJMs and 40+ Lancets) 

REQUEST A MEETING